| Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repression A Radzisheuskaya, D Shlyueva, I Müller, K Helin Nucleic acids research 44 (18), e141-e141, 2016 | 162 | 2016 |
| The human tau interactome: binding to the ribonucleoproteome, and impaired binding of the proline-to-leucine mutant at position 301 (P301L) to chaperones and the proteasome CG Gunawardana, M Mehrabian, X Wang, I Mueller, IB Lubambo, ... Molecular & Cellular Proteomics 14 (11), 3000-3014, 2015 | 115 | 2015 |
| Chromatin modifier HUSH co-operates with RNA decay factor NEXT to restrict transposable element expression W Garland, I Müller, M Wu, M Schmid, K Imamura, L Rib, A Sandelin, ... Molecular cell 82 (9), 1691-1707. e8, 2022 | 67 | 2022 |
| MPP8 is essential for sustaining self-renewal of ground-state pluripotent stem cells I Müller, AS Moroni, D Shlyueva, S Sahadevan, EM Schoof, ... Nature communications 12 (1), 3034, 2021 | 47 | 2021 |
| The SETDB1–TRIM28 complex suppresses antitumor immunity J Lin, D Guo, H Liu, W Zhou, C Wang, I Müller, AV Kossenkov, R Drapkin, ... Cancer immunology research 9 (12), 1413-1424, 2021 | 45 | 2021 |
| Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins X Wang, D Williams, I Müller, M Lemieux, R Dukart, IBL Maia, H Wang, ... Scientific reports 9 (1), 16238, 2019 | 30 | 2019 |
| An organoid-based CRISPR-Cas9 screen for regulators of intestinal epithelial maturation and cell fate SL Hansen, HL Larsen, LM Pikkupeura, G Maciag, J Guiu, I Müller, ... Science Advances 9 (28), eadg4055, 2023 | 27 | 2023 |
| Keep quiet: the HUSH complex in transcriptional silencing and disease I Müller, K Helin Nature Structural & Molecular Biology 31 (1), 11-22, 2024 | 10 | 2024 |
| Effects of centrally administered substance P on cyclic AMP levels in particular brain areas of rats. M Palkovits, G Schmid, U Bahner, I Müller, A Heidland Acta Morphologica Hungarica 38 (3-4), 199-205, 1990 | 8 | 1990 |
| Acute changes in cyclic AMP levels of certain brain areas following intraventricular injection of renin in rats G Schmid, M Palkovits, I Müller, A Heidland Neuropharmacology 21 (1), 3-6, 1982 | 8 | 1982 |
| Abstract C183: Antitumor efficacy of PEG‐Hirudin (LU 87981), administered three times weekly, in an orthotopic AsPC‐1 pancreas carcinoma model N Esser, U Fiedler, R Graeser, T Yu, I Mueller, C Schaechtele Molecular Cancer Therapeutics 8 (12_Supplement), C183-C183, 2009 | 5 | 2009 |
| Rapid Generation of Human Neuronal Cell Models Enabling Inducible Expression of Proteins-of-interest for Functional Studies X Wang, E Friesen, I Müller, M Lemieux, R Dukart, IBL Maia, S Kalia, ... Bio-protocol 10 (9), e3615-e3615, 2020 | | 2020 |
| Abstract C187: Antitumoral efficacy of the novel thrombin inhibitor Revasc©/Desirudin in an orthotopic metastatic AsPC‐1 pancreas tumor model N Esser, U Fiedler, R Graeser, T Yu, I Mueller, C Schaechtele Molecular Cancer Therapeutics 8 (12_Supplement), C187-C187, 2009 | | 2009 |
| Antitumoral efficacy of the novel thrombin inhibitor Revasc (R)/Desirudin in an orthotopic metastatic AsPC-1 pancreas tumor model N Esser, U Fiedler, R Graeser, T Yu, I Mueller, C Schaechtele MOLECULAR CANCER THERAPEUTICS 8 (12), 2009 | | 2009 |
| MINIFOCUS: Cilia and flagella M Stevense, T Muramoto, I Müller, JR Chubb | | |